Komori
Dai-Dan (1980) · InitiativeRestated

Research and Development of Energy-Saving, Clean and Resource-Efficient Technologies

First written in FY2016. 27 of 32 entries say "Restated". Latest entry: FY2026-H1.

32entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2020-Q3RestatedFY2021-Q1 – FY2023-Q3AdvancedFY2024 – FY20252016: 320162017: 420172018: 320182019: 420192020: 420202021: 320212022: 320222023: 420232024: 220242025: 22025
Same theme, other companies
R&D for New Energy and Environmental ProductsA theme 6 companies write about · 0 as a headwind · 6 as a tailwind

1 other company's latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「The amount spent on research and development activities by the Group during the interim consolidated accounting period was ¥644 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」

    The company recorded ¥644 million in research and development expenses and stated that there were no material changes in its research and development activities.
  2. FY2025AdvancedAnnual report

    「Research and development expenses were ¥1,467 million.」

    Research and development expenses increased from ¥1,286 million in the previous fiscal year to ¥1,467 million. The company is compiling research results related to ZEB, equipment quality from a materials perspective, construction DX, regenerative medicine, filter regeneration, CFD, Remobis and other areas.
  3. FY2024AdvancedAnnual report

    「Research and development expenses amounted to ¥1,286 million.」

    Research and development expenses increased from ¥1,174 million in the previous year to ¥1,286 million. The company expanded its research results and activity fields to include ZEB, facilities quality, construction DX, regenerative medicine, filter regeneration, CFD, and Remobis and AI.
  4. FY2024-Q3RestatedAnnual report

    「The group’s research and development expenses for the first nine months of the fiscal year amounted to ¥927 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development expenses of ¥927 million were recorded, and the company states that there were no material changes in the status of its research and development activities.
  5. FY2024-Q2RestatedAnnual report

    「The group’s research and development expenses for the first six months of the fiscal year amounted to ¥578 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development expenses of ¥578 million were recorded, and the company states that there were no material changes in the status of its research and development activities.
  6. FY2024-Q1RestatedAnnual report

    「The group’s research and development expenses for the first three months of the fiscal year amounted to ¥285 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development expenses of ¥285 million were recorded, and the company states that there were no material changes in the status of its research and development activities.
  7. FY2023AdvancedAnnual report

    「Research and development expenses amounted to ¥1,174 million.」

    Research and development expenses increased from ¥1,076 million in the previous year to ¥1,174 million. The company classifies research results in areas including ZEB, cloud-based monitoring and control, construction DX, regenerative medicine, filter regeneration and CFD.
  8. FY2023-Q3RestatedAnnual report

    「The group’s research and development expenses for the first nine months of the fiscal year amounted to ¥888 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development expenses of ¥888 million were recorded, and the company states that there were no material changes in the status of its research and development activities.
  9. FY2023-Q2RestatedAnnual report

    「The group’s research and development expenses for the first six months of the fiscal year amounted to ¥546 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development expenses of ¥546 million were recorded, and the company states that there were no material changes in the status of its research and development activities.
  10. FY2023-Q1RestatedAnnual report

    「The group’s research and development expenses for the first three months of the fiscal year amounted to ¥278 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development activities continued, with research and development expenses of ¥278 million recorded for the first quarter of the fiscal year. The company states that there were no material changes in the status of these activities.
  11. FY2022-Q3RestatedAnnual report

    「The group’s research and development expenses for the first nine months of the fiscal year amounted to ¥731 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development activities continued, with research and development expenses of ¥731 million recorded for the first nine months of the fiscal year. The company states that there were no material changes in the status of these activities.
  12. FY2022-Q2RestatedAnnual report

    「The group’s research and development expenses for the first six months of the fiscal year amounted to ¥317 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Records R&D expenses of ¥317 million and states that there have been no material changes in the status of R&D activities.
  13. FY2022-Q1RestatedAnnual report

    「The group’s research and development expenses for the first three months of the fiscal year amounted to ¥158 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development expenses of ¥158 million were recorded, and the company states that there were no material changes in the status of its research and development activities.
  14. FY2021-Q3RestatedAnnual report

    「The group’s research and development expenses for the first nine months of the fiscal year amounted to ¥368 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development expenses of ¥368 million were recorded, and the company states that there were no material changes in the status of its research and development activities.
  15. FY2021-Q2RestatedAnnual report

    「The group’s research and development expenses for the first six months of the fiscal year amounted to ¥261 million. There were no material changes in the status of the group’s research and development activities during the period.」

    The company states that there were no material changes in its research and development activities and records research and development expenses of ¥261 million for the first six months of the fiscal year.
  16. FY2021-Q1RestatedAnnual report

    「The group’s research and development expenses for the first three months of the fiscal year amounted to ¥126 million. There were no material changes in the status of the group’s research and development activities during the period.」

    The company states that there were no material changes in its research and development activities and records research and development expenses of ¥126 million for the first quarter of the fiscal year.
  17. FY2020AdvancedAnnual report

    「The main research and development results for the fiscal year are as follows. The subsidiaries did not conduct research and development activities. Research and development expenses amounted to ¥778 million.」

    Research and development expenses increased from ¥647 million to ¥778 million. The company classifies ZEB and WELLNESS, IoT and AI, ICT construction, regenerative medicine, and data center technologies as research results and activity fields.
  18. FY2020-Q3RestatedAnnual report

    「The group’s research and development expenses for the first nine months of the fiscal year amounted to ¥440 million. There were no material changes in the status of the group’s research and development activities during the period.」

    The company states that there were no material changes in its research and development activities and records research and development expenses of ¥440 million for the first nine months of the fiscal year.
  19. FY2020-Q2RestatedAnnual report

    「The amount spent on research and development activities by the Group during the cumulative second quarter of the current consolidated fiscal year was ¥285 million. There were no material changes in the Group’s research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    The company states that there were no material changes in its research and development activities and records research and development expenses of ¥285 million for the first six months of the fiscal year.
  20. FY2020-Q1RestatedAnnual report

    「The group’s research and development expenses for the first three months of the fiscal year amounted to ¥150 million. There were no material changes in the status of the group’s research and development activities during the period.」

    The company states that there were no material changes in its research and development activities and records research and development expenses of ¥150 million for the first quarter of the fiscal year.
  21. FY2019RestatedAnnual report

    「The main research and development results for the fiscal year are as follows. The subsidiaries did not conduct research and development activities. Research and development expenses amounted to ¥647 million.」

    Research and development continued in areas including energy savings, clean technologies and effective use of resources, with research and development expenses of ¥647 million recorded for the year.
  22. FY2019-Q3RestatedAnnual report

    「The group’s research and development expenses for the first nine months of the fiscal year amounted to ¥438 million. There were no material changes in the status of the group’s research and development activities during the period.」

    The company states that there were no material changes in its research and development activities and records research and development expenses of ¥438 million for the first nine months of the fiscal year.
  23. FY2019-Q2RestatedAnnual report

    「The group’s research and development expenses for the first six months of the fiscal year amounted to ¥280 million. There were no material changes in the status of the group’s research and development activities during the period.」

    The company states that there were no material changes in its research and development activities and records research and development expenses of ¥280 million for the first six months of the fiscal year.
  24. FY2019-Q1RestatedAnnual report

    「The Group's research and development activities amounted to ¥132 million during the first quarter of the current fiscal year. There were no material changes in the status of the Group's research and development activities during the first quarter of the current fiscal year.」

    The company states that there were no material changes in its research and development activities and records research and development expenses of ¥132 million for the first quarter of the fiscal year.
  25. FY2018-Q3RestatedAnnual report

    「The group’s research and development expenses for the first nine months of the fiscal year amounted to ¥472 million. There were no material changes in the status of the group’s research and development activities during the period.」

    The company states that there were no material changes in its research and development activities and records research and development expenses of ¥472 million for the first nine months of the fiscal year.
  26. FY2018-Q2RestatedAnnual report

    「The group’s research and development expenses for the first six months of the fiscal year amounted to ¥317 million. There were no material changes in the status of the group’s research and development activities during the period.」

    The company states that there were no material changes in its research and development activities and records research and development expenses of ¥317 million for the first six months of the fiscal year.
  27. FY2018-Q1RestatedAnnual report

    「The Group's total research and development expenditure for the first quarter cumulative period was ¥168 million. There were no material changes in the status of the Group's research and development activities during the first quarter cumulative period.」

    The company states that there were no material changes in its research and development activities and records quarterly research and development expenses of ¥168 million.
  28. FY2017RestatedAnnual report

    「Specific research results included the following. The subsidiaries did not conduct research and development activities. Research and development expenses amounted to ¥663 million.」

    Research and development continued in areas including energy savings, clean technologies and effective use of resources, with research and development expenses of ¥663 million recorded for the year.
  29. FY2017-Q3RestatedAnnual report

    「The group’s research and development expenses for the first nine months of the fiscal year amounted to ¥395 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development activities continued, with research and development expenses of ¥395 million recorded for the first nine months of the fiscal year. There were no material changes in the status of these activities.
  30. FY2017-Q2RestatedAnnual report

    「The group’s research and development expenses for the first six months of the fiscal year amounted to ¥262 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development activities continued, with research and development expenses of ¥262 million recorded for the six-month period. There were no material changes in the status of these activities.
  31. FY2017-Q1RestatedAnnual report

    「The group’s research and development expenses for the first nine months of the fiscal year amounted to ¥121 million. There were no material changes in the status of the group’s research and development activities during the period.」

    Research and development activities continued, with research and development expenses of ¥121 million recorded for the quarter. There were no material changes in the status of these activities.
  32. FY2016First statedAnnual report

    「The company focused on energy-saving technologies, including air conditioning for buildings and factories; clean technologies for semiconductor and pharmaceutical applications; and technologies for the effective use of resources, including waste reduction.」

    The specific research and development fields include energy savings, clean technologies and effective use of resources.
Moved together

"Improving Construction Efficiency through i-Construction, ICT, BIM and VR" moved the same way as this thread, in the same document, in 4 of its 32 moves.

443333★123456
  1. ★This thread
  2. 1Improving Construction Efficiency through i-Construction, ICT, BIM and VR4×
  3. 2Applying IoT Technology to Building Systems4×
  4. 3Development of an Air Barrier Booth for Regenerative Medicine3×
  5. 4Creating New Business Areas by Leveraging Technologies for Light, Air and Water3×
  6. 5Personnel Evaluation, Women’s Advancement and Working Environment Improvements3×
  7. 6Rebuilding and Operational Verification of the Kyushu Branch Office ZEB Demonstration Facility3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Dai-Dan's next results are scheduled for 2026-11-11. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.